ANDOVER,
Mass., July 26, 2023 /PRNewswire/ -- TransMedics
Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology
company that is transforming organ transplant therapy for patients
with end-stage lung, heart, and liver failure, announced today
the appointment of Anil Ranganath as Senior Vice President, General
Counsel and Corporate Secretary.
"We are excited to welcome Anil to the TransMedics leadership
team," said Waleed Hassanein, MD,
President and Chief Executive Officer. "Anil brings a wealth of
healthcare industry experience, and his knowledge and counsel will
be invaluable in helping us achieve our growth initiatives."
"It is a pleasure to have the opportunity to join TransMedics at
such an exciting time for the company," said Mr. Ranganath. "I look
forward to collaborating with the entire team to support a range of
growth initiatives and strategies designed to provide industry
leading technology, service, and clinical care to the transplant
community."
Mr. Ranganath brings over 15 years of experience providing
counsel in the life sciences and biotechnology tools industries.
Throughout his career, he served multiple roles of increasing scope
and responsibility at Waters Corporation. Most recently, Mr.
Ranganath served as Vice President, Deputy General Counsel for
Waters, managing legal affairs, and serving as a trusted advisor on
Waters' strategic, tactical, and operational plans. Earlier in his
career, he served as an attorney at Brown Rudnick LLP, representing
life sciences and biotechnology companies on corporate and
intellectual property matters. Mr. Ranganath holds a Juris
Doctorate from Suffolk University Law
School and a bachelor's degree in Computer Science from
Worcester Polytechnic Institute.
About TransMedics Group, Inc.
TransMedics is the
world's leader in portable extracorporeal warm
perfusion and assessment of donor organs for transplantation.
Headquartered in Andover,
Massachusetts, the company was founded to address the unmet
need for more and better organs for transplantation and has
developed technologies to preserve organ quality, assess organ
viability prior to transplant, and potentially increase the
utilization of donor organs for the treatment of end-stage heart,
lung, and liver failure.
Investor Contact:
Brian
Johnston
332-895-3222
Investors@transmedics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/transmedics-appoints-anil-ranganath-as-senior-vice-president-general-counsel-and-corporate-secretary-301886774.html
SOURCE TransMedics Group, Inc.